.png)
.png)
The UK's genomics sector: Poised for continued growth and impact
Genomics has become an integral part of the UK's healthcare system, revolutionising patient care and driving innovation within both small and medium-sized enterprises (SMEs) and large pharmaceutical companies. Our new report, Genomics nation 2023, highlights the profound impact of genomics on the UK's life sciences sector and public health system.
BIA announces its Charity Partnership for 2024 with RNID
BIA is thrilled to announce its charity partnership of the year for 2024 with RNID, the national charity supporting the 12 million people in the UK who are deaf, have hearing loss or tinnitus.
BugBiome wins discovery spark life science programme
BugBiome was announced as the winner of the Discovery Spark life science business support programme at the GIANT Health Healthcare Investment Show on 5th December. BugBiome will be awarded a business support package worth over £100,000, including one year of free lab space at Discovery Park and £50,000 investment from Discovery Park Ventures.
ValiRx seals deal to license late-stage cancer therapy
ValiRx Plc, a life science company focusing on cancer therapeutics and women's health, has announced that ValiRx subsidiary, ValiSeek Ltd, has entered into an exclusive option agreement to license VAL401 with Ambrose Healthcare Ltd, a private UK specialist pharmaceutical company.
Arecor strikes co-development deal for specialty hospital product
Arecor-developed, Arestat™-enabled product is potentially first ready-to-dilute liquid formulation of a high-value oncology therapy
CEO Update - 4 December 2023
UK Biobank is a British success story that puts us at the heart of a key global technology of this century. Last week, UK Biobank published the world’s largest collection of full human genomes. Set up 20 years ago, the charity UK Biobank recruited half a million altruistic volunteers to create the world’s most comprehensive source of health data.
bioProcessUK 2023: Honouring excellence, unveiling future leaders
In a symphony of innovation and camaraderie, the 20th anniversary bioProcessUK conference swept through Brighton, creating an unforgettable experience for the life sciences and biotech community.
Discovery Park Ventures expands fund to fuel UK Sci-Tech Startups
Discovery Park Ventures (DPV) announces the expansion of its early-stage life science fund from £1million to £3 million, in order to capitalise on exciting investment opportunities and support its existing portfolio.
Vast West Midlands laboratory poised to propel UK life sciences
The Rosalind Franklin Laboratory, a state-of-the-art, fully fitted CL2 lab facility in Leamington Spa, Warwickshire, has come to market, with global real estate advisor, Avison Young, promoting it as an ‘unmissable opportunity’ for the UK life sciences sector.
Arecor continues collaboration with Lilly
Development of an enhanced formulation of Lilly proprietary product using Arecor’s formulation technology platform Arestat™